Back

Advances in(TM) Generalized Myasthenia Gravis: Continuing the Quest for Novel Therapies

This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of generalized myasthenia gravis (gMG), with a forward-looking perspective on how new and novel agents might impact clinical practice. The essentials of disease classification, clinical trial data, and current and emerging treatment strategies will be presented.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 1 credit
  • Commercial Support
  • Released
    Jun 30, 2026
  • Last day to claim credit
    Jul 1, 2027 9 months left